Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

ConclusionPatients treated at centers that took longer to implement HER2 testing exhibited worse clinical outcomes. The speed of implementation behaves as a quality-of-care indicator. Reviewed guidelines on HER2 testing should be used to achieve this goal in a timely manner.

http://link.springer.com/10.1007/s10120-016-0639-8

Source: Gastric Cancer - September 5, 2016 Category: Gastroenterology Source Type: research